跳至主要内容
临床试验/NCT03168685
NCT03168685Unknown不适用

Bayer/HITLAB - Hemophilia Mobile App Usability Pilot

Healthcare Innovation Technology Lab1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2017年5月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
1
主要终点
Usage of the SureSource Engage application as assessed by ActiLife software

研究概览

简要总结

The purpose of this study is to evaluate the utility and user experience of a smart phone app for people with medical conditions, used in conjunction with an ActiGraph wearable device and a connected scale.

详细描述

HITLAB will conduct a segmented rapid user acceptance study ("rapid UX study") of a smart phone app and an actigraphy device with a connected scale. During the first segment, of one month's duration, subjects will use the app, actigraphy device, and scale. Next, over an interphase period of up to 6 weeks, subjects will only use the app. During this time, the app will be modified based on data collected during the first segment. Finally, during the second period, also of one month's duration, subjects will use the modified app, actigraphy device, and scale.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 63 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • You own an iPhone or a Samsung (S5 or higher) smartphone
  • Your age is between 18 and 63 years
  • You reside in the New York metropolitan area
  • You are able to read, write, and speak English
  • You have participated in a concluded clinical trial in the past two years

排除标准

  • You do not own an iPhone or a Samsung (S5 or higher) smartphone
  • Your age is not between 18 and 63 years
  • You do not reside in the New York metropolitan area
  • You are not able to read, write, and speak English
  • You have not participated in a concluded clinical trial in the past two years

研究组 & 干预措施

Experimental

Experimental

Multiple device intervention

  1. SureSource Engage mobile application
  2. ActiGraph Link
  3. weight scale

干预措施: SureSource Engage application (Device)

结局指标

主要结局

Usage of the SureSource Engage application as assessed by ActiLife software

时间窗: 128 days

Device usability as assessed by the System Usability Scale (SUS)

时间窗: 128 days

次要结局

未报告次要终点

研究者

发起方
Healthcare Innovation Technology Lab
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验